Dermatology · Inflammatory Skin Conditions

Hidradenitis Suppurativa

USMLE2PANCE
7

Bets

The facts most likely to be tested

1

Hidradenitis suppurativa is a chronic inflammatory follicular occlusion disorder primarily affecting intertriginous areas such as the axillae, groin, and perineum.

Confidence:
2

The clinical hallmark is the presence of recurrent, painful nodules, abscesses, sinus tracts, and double-ended comedones (bridge scars).

Confidence:
3

The Hurley staging system is used to classify disease severity, which dictates the appropriate therapeutic approach.

Confidence:
4

First-line medical management for mild disease involves topical clindamycin, while moderate-to-severe disease requires oral tetracyclines (e.g., doxycycline).

Confidence:
5

Adalimumab is the only FDA-approved TNF-alpha inhibitor for the treatment of moderate-to-severe hidradenitis suppurativa.

Confidence:
6

Surgical intervention, including deroofing or wide local excision, is indicated for refractory sinus tracts and chronic, deep-seated lesions.

Confidence:
7

Smoking cessation and weight loss are critical lifestyle modifications that significantly reduce disease flares and improve long-term outcomes.

Confidence:

Vignette unlocked

A 24-year-old female presents with a 2-year history of recurrent, painful lumps in her axillae and groin. Physical examination reveals multiple erythematous nodules, purulent drainage, and fibrotic sinus tracts in the bilateral axillary regions. She has a history of smoking one pack of cigarettes daily. She has previously failed multiple courses of topical antibiotics. There are no signs of systemic infection.

What is the most appropriate next step in the management of this patient's condition?

+Reveal answer

Initiation of a TNF-alpha inhibitor (e.g., Adalimumab)

The patient presents with moderate-to-severe hidradenitis suppurativa (Hurley stage II/III) that has failed topical therapy, necessitating systemic treatment with a biologic agent like adalimumab.

Mo

Depth

Full handout

High yield triage

Etiology / Epidemiology

Chronic inflammatory disease of apocrine gland-bearing skin; strongly associated with obesity and smoking.

Clinical Manifestations

Recurrent, painful double-comedones and sinus tracts in intertriginous areas.

Diagnosis

A clinical diagnosis based on history of recurrent lesions in characteristic locations.

Treatment

Mild disease: topical clindamycin; moderate/severe: adalimumab.

Prognosis

High risk of squamous cell carcinoma in chronic, non-healing wounds.

Full handout

Epidemiology & Etiology

Common in females (3:1 ratio) with onset typically post-puberty. Strong genetic predisposition noted in 30% of cases. Smoking and obesity are the most significant modifiable risk factors exacerbating disease severity.

Pertinent Anatomy

Affects intertriginous zones including axillae, inguinal, perineal, and inframammary regions. These areas are rich in apocrine glands and hair follicles, which serve as the primary site of follicular occlusion.

Pathophysiology

Begins with follicular hyperkeratosis leading to ductal occlusion and rupture. Subsequent bacterial colonization triggers a robust inflammatory response, resulting in abscesses and sinus tracts. Chronic inflammation leads to extensive fibrosis and scarring.

Clinical Manifestations

Presents as painful, erythematous nodules that progress to double-comedones (pathognomonic). Patients develop sinus tracts and bridge scarring in the axilla or groin. Sepsis or cellulitis are rare but serious acute complications.

Diagnosis

Primarily a clinical diagnosis. No specific laboratory test exists. The Hurley staging system is used to classify severity (Stage I: abscesses; Stage II: sinus tracts; Stage III: diffuse involvement).

Treatment

First-line for mild disease is topical clindamycin. For moderate-to-severe cases, adalimumab is the only FDA-approved biologic. Avoid systemic corticosteroids for long-term management due to limited efficacy and side effects. Surgical excision is reserved for refractory, localized disease.

Prognosis

Chronic, relapsing course requiring long-term management. Squamous cell carcinoma is a rare but critical long-term complication of chronic, draining sinus tracts. Monitor for signs of malignant transformation in non-healing ulcers.

Differential Diagnosis

Furunculosis: usually solitary, lacks sinus tracts

Lymphadenitis: associated with systemic symptoms/lymphadenopathy

Crohn's disease: check for perianal fistulas and GI symptoms

Actinomycosis: presents with sulfur granules and woody induration

Folliculitis: superficial, lacks deep scarring/tracts